Zacks Research Upgrades Haleon (NYSE:HLN) to “Hold”

Haleon (NYSE:HLN) was upgraded by Zacks Research from a “strong sell” rating to a “hold” rating in a report issued on Wednesday,Zacks.com reports.

Other research analysts also recently issued reports about the company. Royal Bank Of Canada reissued a “sector perform” rating on shares of Haleon in a research note on Tuesday, August 11th. Wall Street Zen raised shares of Haleon from a “hold” rating to a “buy” rating in a research note on Sunday, July 12th. Morgan Stanley reiterated an “overweight” rating on shares of Haleon in a research report on Thursday, August 6th. Weiss Ratings restated a “hold (c)” rating on shares of Haleon in a research report on Tuesday, June 30th. Finally, Rothschild & Co Redburn cut Haleon from a “strong-buy” rating to a “hold” rating in a report on Tuesday, June 16th. Two analysts have rated the stock with a Strong Buy rating, three have given a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Haleon presently has a consensus rating of “Moderate Buy”.

Haleon Stock Performance

NYSE HLN opened at $9.87 on Wednesday. The company has a debt-to-equity ratio of 0.38, a current ratio of 0.69 and a quick ratio of 0.52. The stock’s 50 day simple moving average is $9.67 and its 200-day simple moving average is $9.82. The company has a market cap of $43.47 billion, a PE ratio of 25.31, a price-to-earnings-growth ratio of 1.97 and a beta of 0.12. Haleon has a 1-year low of $8.65 and a 1-year high of $11.28.

Institutional Trading of Haleon

Several hedge funds have recently made changes to their positions in the company. Bank of America Corp DE lifted its holdings in shares of Haleon by 17.0% in the 1st quarter. Bank of America Corp DE now owns 10,934,228 shares of the company’s stock worth $109,452,000 after acquiring an additional 1,586,230 shares during the last quarter. Goodman Financial Corp acquired a new stake in Haleon in the 1st quarter valued at approximately $11,488,000. First Eagle Investment Management LLC increased its holdings in Haleon by 9.1% in the 4th quarter. First Eagle Investment Management LLC now owns 3,335,583 shares of the company’s stock valued at $33,723,000 after purchasing an additional 278,632 shares during the last quarter. UBS Group AG increased its holdings in Haleon by 107.4% in the 4th quarter. UBS Group AG now owns 995,987 shares of the company’s stock valued at $10,069,000 after purchasing an additional 515,670 shares during the last quarter. Finally, Milford Funds Ltd. purchased a new stake in Haleon in the fourth quarter valued at approximately $1,820,000. Hedge funds and other institutional investors own 6.67% of the company’s stock.

About Haleon

Haleon plc (NYSE:HLN) is a global consumer healthcare company formed through the separation of a large pharmaceutical group’s consumer health business in 2022. Headquartered in the United Kingdom, Haleon develops, manufactures and markets a broad portfolio of over‑the‑counter medicines, oral health products, vitamins, minerals and supplements, and other consumer health goods designed for daily self‑care and symptom relief.

The company’s product mix spans categories such as oral care (toothpastes and sensitivity treatments), pain relief and analgesics, respiratory remedies, digestive health products, topical treatments and nutritional supplements.